Alvarez Ralph bought LLY
February 18, 2025 · Form 4 insider transaction
Alvarez Ralph bought 13.708 shares of Eli Lilly and Company at $857.20 per share, a transaction worth $11.8K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
13.708
Price
$857.20
Total value
$11.8K
InsiderAlvarez Ralph
Role—
CompanyEli Lilly and Company (LLY)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2025
Filing dateFebruary 19, 2025
Shares owned after54,719
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.